Related Experiment Videos
Brain metastases from endometrial carcinoma
1Department of Obstetrics and Gynecology, University of Milan, Istituto di Scienze Biomediche, Monza, Italy.
Gynecologic Oncology
|April 1, 1996
Summary
Central nervous system involvement from endometrial carcinoma is rare, with brain metastases affecting less than 1% of patients. Early diagnosis and multimodal treatment may improve outcomes for this poor-prognosis condition.
Area of Science:
- Neurology
- Oncology
- Gynecologic Oncology
Background:
- Central nervous system (CNS) involvement is an uncommon complication of endometrial carcinoma.
- This study reviews cases of endometrial carcinoma with brain metastases.
Purpose of the Study:
- To investigate the incidence, clinical presentation, and outcomes of endometrial carcinoma patients who develop brain metastases.
- To evaluate the effectiveness of different treatment modalities for CNS involvement.
Main Methods:
- Retrospective review of 1069 endometrial carcinoma patients diagnosed between 1982 and 1994.
- Analysis of clinical data, diagnostic imaging (CT scans), treatment strategies, and survival outcomes for patients with CNS metastases.
Main Results:
- 0.9% (10 patients) developed brain metastases, with a median age of 59 years and a median interval of 26 months from endometrial cancer diagnosis.
- Common symptoms included headache, motor weakness, and seizures. Lesions were contrast-enhancing on CT scans.
- Median survival was poor at 1 month. Multimodal treatment (surgery and radiotherapy) offered better survival in selected cases (28 and 83 months).
Conclusions:
- CNS metastases from endometrial carcinoma have a poor prognosis.
- Early diagnosis and a multimodal treatment approach, including surgery and radiotherapy, may offer palliative benefits in select patients.